Option Care Health OPCH
- Market cap
- $4.7B
- PE
- 23.5×
- 5y median 26.4×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.8×
- EV/EBIT
- 16.9×
- Revenue, 12 months
- $5.7B
- +6% on a year ago
- Net margin
- 3.7%
- Free cash flow yield
- 6.5%
Option Care Health trades at 23.5× trailing earnings, cheaper than 66% of the last ten years. Revenue was $5.7B over the last twelve months, up 6% on a year earlier with a 4% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.1B+7% | $1.1B+10% | $1.1B+13% | $1.2B+15% | $1.3B+17% | $1.3B+20% | $1.3B+16% | $1.4B+15% | $1.4B+12% | $1.5B+9% | $1.4B+1% | $1.4B+2% | |
| Cost of revenue | $838.7M+5% | $877.3M+10% | $907.6M+15% | $977.8M+20% | $1B+22% | $1.1B+23% | $1.1B+18% | $1.1B+17% | $1.2B+14% | $1.2B+10% | $1.1B+2% | $1.2B+3% |
| Gross profit | $254.3M+17% | $247.1M+7% | $238.5M+4% | $249.4M−1% | $256.7M+1% | $268.4M+9% | $263.1M+10% | $269M+8% | $272.9M+6% | $282.9M+5% | $262M−0% | $267.3M−1% |
| SG&A | $158.2M+11% | $147.8M−0% | $154.7M+5% | $153.8M+0% | $157M−1% | $164.7M+12% | $168.1M+9% | $170.1M+11% | $172.1M+10% | $172.1M+5% | $174.6M+4% | $164.7M−3% |
| $81M+34% | $84.6M+24% | $69M+4% | $80.7M−2% | $85.1M+5% | $87M+3% | $79.2M+15% | $82.7M+3% | $84.5M−1% | $91.5M+5% | $72.5M−8% | $85.1M+3% | |
| Interest expense | $11.8M−16% | $12.4M−16% | $13.2M−5% | $12.6M−5% | $12.3M+5% | $10.9M−13% | $13.2M+0% | $14.4M+15% | $14.1M+15% | $12.7M+17% | $13.3M+1% | $14M−3% |
| Pre-tax income | $70.1M+35% | $78.9M+22% | $57M+5% | $72M−54% | $73.6M+5% | $81M+3% | $63.6M+12% | $68.9M−4% | $69M−6% | $81.5M+1% | $61M−4% | $74M+7% |
| $13.8M+4% | $21.7M+26% | $12.2M−19% | $19M−54% | $19.7M+43% | $20.9M−4% | $16.8M+38% | $18.3M−4% | $17.2M−13% | $23M+10% | $15.7M−7% | $20.1M+10% | |
| Net income | $56.3M+45% | $57.2M+20% | $44.8M+14% | $53M−54% | $53.9M−4% | $60.1M+5% | $46.7M+4% | $50.5M−5% | $51.8M−4% | $58.5M−3% | $45.3M−3% | $53.9M+7% |
| $0.31+48% | $0.32+23% | $0.26+24% | $0.30−52% | $0.31+0% | $0.35+9% | $0.28+8% | $0.31+3% | $0.32+3% | $0.37+6% | $0.29+4% | $0.35+13% | |
| 180.5M−1% | 177.7M−3% | 175.6M−4% | 174.1M−4% | 171.9M−5% | 169.9M−4% | 166.8M−5% | 164.1M−6% | 163.1M−5% | 159.7M−6% | 158.2M−5% | 153.5M−7% |
Operating income: 9 periods, Q2 FY15 to Q3 FY17: not printed by the filing, worked out from its own lines.
EPS, diluted: 13 periods, Q4 FY08 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 7 periods, Q4 FY08 to Q4 FY19: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 9 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY18: share-days: the 12-month average over 365 days less the 9-month over 273, the two on one basis (x4).
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Medical - Care Facilities nearest Option Care Health's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| OPCHOption Care Health | $4.7B | 23.5× | 26.4× | 0.8× | +6% | 3.7% | |
| LFSTLifeStance Health | $4.9B | 99.5× | 142× | 3.1× | +20% | 3.2% | |
| CONConcentra Group Holdings Parent | $5B | 25.5× | 17.5× | 2.2× | +14% | 8.7% | |
| SHCSotera Health | $5.2B | 31.8× | 55.4× | 4.2× | +8% | 13.4% | |
| NHCNational Healthcare | $3.7B | 26.5× | 21.4× | 2.4× | +7% | 9.0% | |
| CHEChemed | $6.7B | 25.8× | 29.0× | 2.6× | +3% | 10.6% | |
| AVAHAveanna Healthcare | $2.9B | 10.9× | 21.8× | 1.1× | +20% | 10.6% | |
| PACSPACS | $7.5B | 27.2× | 27.2× | 1.4× | +15% | 4.8% | |
| PRVAPrivia Health | $2.9B | 107× | 158× | 1.2× | +24% | 1.2% | |
| MDPediatrix Medical | $2.4B | 14.0× | 13.4× | 1.2× | +1% | 9.0% | |
| ADUSAddus HomeCare | $2.3B | 21.4× | 32.4× | 1.5× | +16% | 7.1% | |
| Peer median | $4.3B | 26.1× | 28.1× | 1.9× | +15% | 8.8% |
Investors who own it
Investors we follow who held Option Care Health at the end of Jun 30, 2026, from their 13F filings.
- Henry EllenbogenDurable Capital Partners1.3% of portfoliotrimmed
More on Option Care Health
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .